TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 29 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $14,106,000 | -61.0% | 803,339 | -78.4% | 0.01% | -64.3% |
| Q2 2021 | $36,134,000 | -3.1% | 3,725,235 | +7.3% | 0.01% | -6.7% |
| Q1 2021 | $37,303,000 | -26.4% | 3,473,405 | +0.8% | 0.02% | -28.6% |
| Q4 2020 | $50,708,000 | +28.3% | 3,447,134 | +23.9% | 0.02% | +10.5% |
| Q3 2020 | $39,525,000 | +219.0% | 2,781,440 | +83.6% | 0.02% | +216.7% |
| Q2 2020 | $12,392,000 | +102.5% | 1,514,900 | 0.0% | 0.01% | +50.0% |
| Q1 2020 | $6,120,000 | +6776.4% | 1,514,900 | +7399.5% | 0.00% | – |
| Q2 2017 | $89,000 | -96.4% | 20,200 | -94.9% | 0.00% | -100.0% |
| Q1 2017 | $2,439,000 | +9.3% | 395,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $2,232,000 | -61.8% | 395,000 | 0.0% | 0.00% | -66.7% |
| Q3 2016 | $5,838,000 | +64.6% | 395,000 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $3,547,000 | -2.9% | 395,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,654,000 | -26.6% | 395,000 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $4,981,000 | -3.2% | 395,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $5,147,000 | -40.3% | 395,000 | 0.0% | 0.00% | -25.0% |
| Q2 2015 | $8,619,000 | – | 395,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|